scholarly article | Q13442814 |
P2093 | author name string | Robert L Fairchild | |
Anna Valujskikh | |||
Michael Nicosia | |||
P2860 | cites work | Total Recall: Can We Reshape T Cell Memory by Lymphoablation? | Q39020489 |
Crosstalk Between T and B Cells in the Germinal Center After Transplantation. | Q39025865 | ||
T memory stem cells in health and disease. | Q39070577 | ||
LFA-1 antagonism inhibits early infiltration of endogenous memory CD8 T cells into cardiac allografts and donor-reactive T cell priming | Q39101460 | ||
Role of Memory T Cells in Allograft Rejection and Tolerance | Q39178547 | ||
Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity | Q39192241 | ||
Constitutive Glycolytic Metabolism Supports CD8(+) T Cell Effector Memory Differentiation during Viral Infection. | Q39194568 | ||
Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming. | Q39689532 | ||
Allo-HLA reactivity of virus-specific memory T cells is common | Q39738689 | ||
Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. | Q40459668 | ||
Liver-Resident Memory CD8+ T Cells Form a Front-Line Defense against Malaria Liver-Stage Infection | Q40499837 | ||
Effect of Anti-IL-15 Administration on T Cell and NK Cell Homeostasis in Rhesus Macaques. | Q40645100 | ||
Are primary alloresponses truly primary? | Q41138782 | ||
Identification of mouse T follicular helper cells by flow cytometry. | Q41360257 | ||
Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention | Q41520161 | ||
Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model | Q41723730 | ||
Tolerance of Lung Allografts Achieved in Nonhuman Primates via Mixed Hematopoietic Chimerism | Q41808450 | ||
Integrin antagonists for transplant immunosuppression: panacea or peril? | Q42108235 | ||
An IL-27/Lag3 axis enhances Foxp3+ regulatory T cell-suppressive function and therapeutic efficacy. | Q42114498 | ||
Spatial map of human T cell compartmentalization and maintenance over decades of life | Q42159822 | ||
Belatacept Does Not Inhibit Follicular T Cell-Dependent B-Cell Differentiation in Kidney Transplantation. | Q42235846 | ||
Endogenous memory CD8 T cells directly mediate cardiac allograft rejection | Q42238758 | ||
The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. | Q42259563 | ||
Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study | Q42268606 | ||
Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells. | Q42283389 | ||
AMPKα1: a glucose sensor that controls CD8 T-cell memory | Q42539376 | ||
Memory CD4 T Cells Induce Antibody-Mediated Rejection of Renal Allografts | Q42722907 | ||
Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes. | Q42767129 | ||
Phenotypic and functional separation of memory and effector human CD8+ T cells | Q42951823 | ||
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). | Q44247085 | ||
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions | Q44443175 | ||
IMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I study | Q21245663 | ||
LAG-3, a novel lymphocyte activation gene closely related to CD4 | Q24300309 | ||
Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity | Q24604251 | ||
Posttranscriptional control of T cell effector function by aerobic glycolysis | Q24606942 | ||
mTOR signaling in growth control and disease | Q24634174 | ||
Memory T follicular helper CD4 T cells | Q26829047 | ||
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 | ||
Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets | Q28278055 | ||
Host-reactive CD8+ memory stem cells in graft-versus-host disease | Q28281894 | ||
HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia | Q28300406 | ||
Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes | Q28588804 | ||
Central memory and effector memory T cell subsets: function, generation, and maintenance | Q29615097 | ||
Safety profile, pharmacokinetics, and pharmacodynamics of siplizumab, a humanized anti-CD2 monoclonal antibody, in renal allograft recipients | Q30449471 | ||
Central memory CD8+ T lymphocytes mediate lung allograft acceptance. | Q30573064 | ||
CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin | Q33390838 | ||
HLA-mismatched renal transplantation without maintenance immunosuppression | Q33640791 | ||
HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE. | Q33717763 | ||
Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris | Q33757065 | ||
Herpes Simplex Virus-Specific Memory CD8+ T Cells Are Selectively Activated and Retained in Latently Infected Sensory Ganglia | Q33854496 | ||
IL-15 Harnesses Pro-inflammatory Function of TEMRA CD8 in Kidney-Transplant Recipients. | Q33857540 | ||
Expansion of highly differentiated cytotoxic terminally differentiated effector memory CD8+ T cells in a subset of clinically stable kidney transplant recipients: a potential marker for late graft dysfunction | Q33974650 | ||
Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. | Q33997387 | ||
Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response | Q34078561 | ||
Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+) )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates. | Q34166913 | ||
Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo | Q34315262 | ||
Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease. | Q34360724 | ||
The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells | Q34417483 | ||
Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. | Q34496604 | ||
Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells | Q34524226 | ||
Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis | Q34550475 | ||
The CD8⁺ memory stem T cell (T(SCM)) subset is associated with improved prognosis in chronic HIV-1 infection | Q34594094 | ||
IMP321 (sLAG-3) safety and T cell response potentiation using an influenza vaccine as a model antigen: a single-blind phase I study | Q34627136 | ||
Memory CD4 T cells that express CXCR5 provide accelerated help to B cells | Q34754506 | ||
Tissue-resident memory T cells. | Q34769660 | ||
Low frequency of circulating CD8+ T stem cell memory cells in chronic chagasic patients with severe forms of the disease | Q34874190 | ||
Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion- blockade decrease rejection | Q34937146 | ||
Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates | Q34991139 | ||
A phase I pharmacokinetic and biological correlative study of IMP321, a novel MHC class II agonist, in patients with advanced renal cell carcinoma | Q35003023 | ||
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus | Q35012624 | ||
Heterologous immunity provides a potent barrier to transplantation tolerance | Q35095576 | ||
Regulation of quiescence in lymphocytes | Q35177712 | ||
Proinflammatory microenvironments within the intestine regulate the differentiation of tissue-resident CD8⁺ T cells responding to infection | Q35202406 | ||
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation | Q35242438 | ||
Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. | Q35404457 | ||
Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy | Q35418255 | ||
Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. | Q35586076 | ||
Quantifying Memory CD8 T Cells Reveals Regionalization of Immunosurveillance | Q35591980 | ||
T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses | Q35667029 | ||
Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates | Q35675449 | ||
Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties | Q35861157 | ||
Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis | Q35868862 | ||
Tolerance induction in clinical transplantation | Q35893656 | ||
Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues | Q35936035 | ||
Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease | Q35998783 | ||
Long-term lung transplantation in nonhuman primates | Q36044857 | ||
Memory T cells and their exhaustive differentiation in allograft tolerance and rejection | Q36095846 | ||
Metabolic regulation of organelle homeostasis in lupus T cells | Q36177195 | ||
Costimulation blockade in pig artery patch xenotransplantation - a simple model to monitor the adaptive immune response in nonhuman primates | Q36192829 | ||
Preventing Allograft Rejection by Targeting Immune Metabolism | Q36225691 | ||
The emerging role of resident memory T cells in protective immunity and inflammatory disease | Q36267804 | ||
Fuel feeds function: energy metabolism and the T-cell response | Q36292868 | ||
Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells | Q36305532 | ||
The challenge of inhibiting alloreactive T-cell memory | Q36422118 | ||
Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. | Q44635346 | ||
Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. | Q44660648 | ||
Thrombophilia associated with anti-CD154 monoclonal antibody treatment and its prophylaxis in nonhuman primates | Q44765909 | ||
Premature aging of circulating T cells in patients with end-stage renal disease. | Q44954889 | ||
Immunocompetent T-cells with a memory-like phenotype are the dominant cell type following antibody-mediated T-cell depletion | Q45262215 | ||
Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus | Q45385806 | ||
Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. | Q45964495 | ||
Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. | Q46007205 | ||
Lymphoid sequestration of alloreactive memory CD4 T cells promotes cardiac allograft survival | Q46880078 | ||
T Follicular Helper Cells As a New Target for Immunosuppressive Therapies. | Q47109235 | ||
BTI-322 for acute rejection after renal transplantation | Q47620159 | ||
In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy | Q47725793 | ||
Aquaporin 4 blockade improves survival of murine heart allografts subjected to prolonged cold ischemia | Q47754464 | ||
Calcineurin inhibitors dampen humoral immunity by acting directly on naive B cells. | Q49159423 | ||
Allograft dendritic cell p40 homodimers activate donor-reactive memory CD8+ T cells. | Q50535445 | ||
Pregnancy persistently affects memory T cell populations. | Q50610830 | ||
Uremia-associated immunological aging is stably imprinted in the T-cell system and not reversed by kidney transplantation. | Q50789254 | ||
T-follicular helper cells survive as long-term memory cells. | Q50949455 | ||
Terminally differentiated CD8+ Temra cells are associated with the risk for acute kidney allograft rejection. | Q50951069 | ||
Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection. | Q51060341 | ||
Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. | Q51541351 | ||
Donor-Specific Antibodies Are Produced Locally in Ectopic Lymphoid Structures in Cardiac Allografts. | Q51634522 | ||
Alefacept treatment for refractory chronic extensive GVHD. | Q51961388 | ||
Changes in circulating lymphocyte subpopulations following administration of the leucocyte function-associated antigen-3 (LFA-3)/IgG1 fusion protein alefacept. | Q51976501 | ||
Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. | Q51985053 | ||
Heterogeneity of the memory CD4 T cell response: persisting effectors and resting memory T cells. | Q52022231 | ||
Mechanisms of Mixed Chimerism-Based Transplant Tolerance. | Q53102364 | ||
Positive correlation of T cell sensitization with frequencies of alloreactive T helper cells in chronic renal failure patients | Q54265472 | ||
The Calcineurin Inhibitor Tacrolimus Specifically Suppresses Human T Follicular Helper Cells. | Q55373807 | ||
Metabolic Reprogramming and Longevity of Tissue-Resident Memory T Cells. | Q55437503 | ||
Resident-Memory T Cells in Tissue-Restricted Immune Responses: For Better or Worse? | Q59798737 | ||
Donor CD4 T Cells Contribute to Cardiac Allograft Vasculopathy by Providing Help for Autoantibody Production | Q60056590 | ||
Characterization of donor and recipient CD8+ tissue-resident memory T cells in transplant nephrectomies | Q64052882 | ||
Aquaporin 4 inhibition alters chemokine receptor expression and T cell trafficking | Q64259248 | ||
Acceptance of primary skin graft after treatment with anti-intercellular adhesion molecule-1 and anti-leukocyte function-associated antigen-1 monoclonal antibodies in mice | Q71463422 | ||
T cells primed by Leishmania major infection cross-react with alloantigens and alter the course of allograft rejection | Q74817270 | ||
Proliferation and differentiation potential of human CD8+ memory T-cell subsets in response to antigen or homeostatic cytokines | Q78952589 | ||
Total body irradiation of donors can alter the course of tolerance and induce acute rejection in a spontaneous tolerance rat liver transplantation model | Q87383421 | ||
Safety and pharmacodynamics of anti-CD2 monoclonal antibody treatment in cynomolgus macaques - an experimental study | Q90118137 | ||
PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21 | Q90178396 | ||
Cutting Edge: IL-27 Attenuates Autoimmune Neuroinflammation via Regulatory T Cell/Lag3-Dependent but IL-10-Independent Mechanisms In Vivo | Q91283115 | ||
Atypical motifs in the cytoplasmic region of the inhibitory immune co-receptor LAG-3 inhibit T cell activation | Q91556458 | ||
Memory T-cell exhaustion and tolerance in transplantation | Q91746565 | ||
Dysfunctional peripheral T follicular helper cells dominate in people with impaired influenza vaccine responses: Results from the FLORAH study | Q92112986 | ||
Generation and persistence of human tissue-resident memory T cells in lung transplantation | Q92235155 | ||
IL-7-Induced Glycerol Transport and TAG Synthesis Promotes Memory CD8+ T Cell Longevity | Q36439775 | ||
Memory Stem T Cells in Autoimmune Disease: High Frequency of Circulating CD8+ Memory Stem Cells in Acquired Aplastic Anemia. | Q36553599 | ||
Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets | Q36569494 | ||
CD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell Proliferation | Q36633574 | ||
Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. | Q36639793 | ||
Metabolic switching and fuel choice during T-cell differentiation and memory development | Q36820974 | ||
CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection | Q36901437 | ||
Normalizing the environment recapitulates adult human immune traits in laboratory mice | Q36912671 | ||
Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. | Q36995837 | ||
Distinct memory CD4+ T cells with commitment to T follicular helper- and T helper 1-cell lineages are generated after acute viral infection. | Q37090620 | ||
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. | Q37200886 | ||
Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft | Q37203108 | ||
Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview. | Q37288737 | ||
Depleting T-cell subpopulations in organ transplantation | Q37316082 | ||
Activated lymphocytes as a metabolic model for carcinogenesis. | Q37326607 | ||
Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells | Q37352068 | ||
Homeostasis of naive and memory T cells | Q37356053 | ||
IL-15-Independent Maintenance of Tissue-Resident and Boosted Effector Memory CD8 T Cells. | Q37485997 | ||
Lung-resident memory CD8 T cells (TRM) are indispensable for optimal cross-protection against pulmonary virus infection | Q37496801 | ||
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy | Q37630991 | ||
Cutting edge: resident memory CD8 T cells occupy frontline niches in secondary lymphoid organs | Q37662759 | ||
Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. | Q37688914 | ||
Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection | Q37700827 | ||
Solid Organ Transplant-Associated Acute Graft-Versus-Host Disease | Q37776504 | ||
The structural basis of alloreactivity | Q37928666 | ||
Regulation of immune responses by mTOR. | Q37963950 | ||
Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs | Q37965743 | ||
From "truly naïve" to "exhausted senescent" T cells: when markers predict functionality | Q38152430 | ||
Targeting T cell metabolism for therapy | Q38324388 | ||
Tissue-Resident Memory T Cells and Fixed Immune Surveillance in Nonlymphoid Organs | Q38532832 | ||
Memory T cells in organ transplantation: progress and challenges | Q38753494 | ||
Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. | Q38951617 | ||
Implications of Resident Memory T Cells for Transplantation | Q38996466 | ||
Airway-Resident Memory CD8 T Cells Provide Antigen-Specific Protection against Respiratory Virus Challenge through Rapid IFN-γ Production | Q39001253 | ||
P407 | language of work or name | English | Q1860 |
P577 | publication date | 2020-02-07 | |
P1433 | published in | Transplantation | Q15730500 |
P1476 | title | Memory T cells in transplantation: old challenges define new directions |
Search more.